4.1 Performance review of our people
The development and retention of UCB’s people is of paramount importance to become the patient preferred biopharma leader. In the review of the Material Topics, people development and people management are considered very relevant Material Aspects.
UCB is also driven by a high-performance culture. Therefore, an annual Performance Management process is in place allowing people to concentrate on value-driven actions and outcomes, and directly seek continuous feedback to contribute to UCB’s Strategic Priorities throughout the year. By the end of January 2019, the Year End Performance Review process was completed for 90% of UCB employees. People are rewarded and acknowledged for their individual contribution to the company’s success.
UCB’s approach to the patient is innovative. I have never seen or heard of a pharmaceutical company that works in such a way for the patient. This includes the affection and the interest that they show towards the patients and how they fully consider and value our opinions. Thanks to UCB.
The Talent and Organization review process is designed to identify key talents in our organization and initiate various action plans to develop, retain and engage our colleagues. The process also demands that the managers identify appropriate successors and prepare them for the most business critical positions. The review process is critical for UCB as it equally enables the identiﬁcation of capability needs for the organization and supports the long-term success and sustainability of the company.
A total of 6 007 people were subject of the 2018 Talent and Organization Review, completed in November 2018. A total of 2 072 colleagues were identiﬁed as high potentials, with 330 colleagues as Top Talents.